| Year |
Citation |
Score |
| 2023 |
Farquhar DR, Masood MM, Lenze NR, Tasoulas J, Sheth S, Lumley C, Blumberg J, Yarbrough WG, Zevallos J, Weissler MC, Zanation AM, Hackman TG, Olshan AF. Effect of distance of treatment center on survival for HPV-negative head and neck cancer patients. Head & Neck. PMID 37767817 DOI: 10.1002/hed.27522 |
0.338 |
|
| 2023 |
Schrank TP, Kothari A, Weir WH, Stepp WH, Rehmani H, Liu X, Wang X, Sewell A, Li X, Tasoulas J, Kim S, Yarbrough G, Xie Y, Flamand Y, Marur S, ... ... Yarbrough WG, et al. Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors. Proceedings of the National Academy of Sciences of the United States of America. 120: e2216532120. PMID 37523561 DOI: 10.1073/pnas.2216532120 |
0.32 |
|
| 2022 |
Morse RT, Beaty B, Scanga L, Blumberg J, Patel S, Yarbrough WG, Lumley C, Hackman T, Shen C, Gupta GP, Chera BS. Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma. Oral Oncology. 134: 106131. PMID 36191480 DOI: 10.1016/j.oraloncology.2022.106131 |
0.301 |
|
| 2022 |
Papini C, Wang Z, Kudalkar SN, Schrank TP, Tang S, Sasaki T, Wu C, Tejada B, Ziegler SJ, Xiong Y, Issaeva N, Yarbrough WG, Anderson KS. Exploring ABOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer. Iscience. 25: 105077. PMID 36164654 DOI: 10.1016/j.isci.2022.105077 |
0.326 |
|
| 2022 |
Murphy RM, Tasoulas J, Porrello A, Carper MB, Tsai YH, Coffey AR, Kumar S, Zeng PY, Schrank TP, Midkiff BR, Cohen S, Salazar AH, Hayward MC, Hayes DN, Olshan A, ... ... Yarbrough WG, et al. Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer. Cancer Research Communications. 2: 987-1004. PMID 36148399 DOI: 10.1158/2767-9764.crc-21-0135 |
0.36 |
|
| 2022 |
Carper MB, Goel S, Zhang AM, Damrauer JS, Cohen S, Zimmerman MP, Gentile GM, Parag-Sharma K, Murphy RM, Sato K, Nickel KP, Kimple RJ, Yarbrough WG, Amelio AL. Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer. Neoplasia (New York, N.Y.). 29: 100799. PMID 35504112 DOI: 10.1016/j.neo.2022.100799 |
0.329 |
|
| 2021 |
Lenze NR, Farquhar DR, Sheth S, Zevallos JP, Lumley C, Blumberg J, Patel S, Hackman T, Weissler MC, Yarbrough WG, Olshan AF, Zanation AM. Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma. Oral Oncology. 119: 105377. PMID 34161897 DOI: 10.1016/j.oraloncology.2021.105377 |
0.304 |
|
| 2021 |
Torabi SJ, Kasle DA, Su-Velez BM, Mehra S, Day TA, Yarbrough WG, St John M, Judson BL. A 2020 Update on Public Awareness of Head and Neck Cancers. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 1945998211006932. PMID 33845657 DOI: 10.1177/01945998211006932 |
0.309 |
|
| 2021 |
Schrank TP, Lenze N, Landess LP, Hoyle A, Parker J, Lal A, Sheth S, Chera BS, Patel SN, Hackman TG, Major MB, Issaeva N, Yarbrough WG. Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx. Cancer. PMID 33819343 DOI: 10.1002/cncr.33504 |
0.317 |
|
| 2020 |
Hajek M, Biktasova A, Sewell A, Gary C, Cantalupo P, Anderson KS, Yarbrough WG, Issaeva N. Global Genome Demethylation Causes Transcription-Associated DNA Double Strand Breaks in HPV-Associated Head and Neck Cancer Cells. Cancers. 13. PMID 33374558 DOI: 10.3390/cancers13010021 |
0.3 |
|
| 2020 |
Lenze NR, Farquhar D, Sheth S, Zevallos JP, Blumberg J, Lumley C, Patel S, Hackman T, Weissler MC, Yarbrough WG, Zanation AM, Olshan AF. Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes. The Laryngoscope. PMID 33170518 DOI: 10.1002/lary.29252 |
0.329 |
|
| 2020 |
Stein E, Lenze NR, Yarbrough WG, Hayes DN, Mazul A, Sheth S. Systematic review and meta-analysis of racial survival disparities among oropharyngeal cancer cases by HPV status. Head & Neck. PMID 32632953 DOI: 10.1002/hed.26328 |
0.303 |
|
| 2020 |
Farquhar DR, Lenze NR, Masood MM, Divaris K, Tasoulas J, Blumberg J, Lumley C, Patel S, Hackman T, Weissler MC, Yarbrough W, Zanation AM, Olshan AF. Access to preventive care services and stage at diagnosis in head and neck cancer. Head & Neck. PMID 32618052 DOI: 10.1002/Hed.26326 |
0.328 |
|
| 2020 |
Chera BS, Kumar S, Shen C, Amdur R, Dagan R, Green R, Goldman E, Weiss J, Grilley-Olson J, Patel S, Zanation A, Hackman T, Blumberg J, Patel S, Thorp B, ... ... Yarbrough W, et al. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902444. PMID 32017652 DOI: 10.1200/Jco.19.02444 |
0.413 |
|
| 2020 |
Yarbrough W, Issaeva N. Predictive Genetic Biomarkers of Survival in HPV-associated HNSCC International Journal of Radiation Oncology*Biology*Physics. 106: 1223. DOI: 10.1016/J.Ijrobp.2020.02.007 |
0.345 |
|
| 2019 |
Loganadane G, Kann BH, Park HS, Johnson SB, Mehra S, Judson BL, Bhatia A, Belkacemi Y, Yarbrough WG, Burtness B, Husain ZA. Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy. Anticancer Research. 39: 4885-4890. PMID 31519591 DOI: 10.21873/anticanres.13674 |
0.356 |
|
| 2019 |
Chera BS, Amdur RJ, Green R, Shen C, Gupta G, Tan X, Knowles M, Fried D, Hayes N, Weiss J, Grilley-Olson J, Patel S, Zanation A, Hackman T, Zevallos J, ... ... Yarbrough W, et al. Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901007. PMID 31411949 DOI: 10.1200/Jco.19.01007 |
0.347 |
|
| 2019 |
Pan C, Izreig S, Yarbrough WG, Issaeva N. NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents. Cancers of the Head & Neck. 4: 3. PMID 31321084 DOI: 10.1186/s41199-019-0042-3 |
0.34 |
|
| 2019 |
Lee JW, Parameswaran J, Sandoval-Schaefer T, Eoh KJ, Yang DH, Zhu F, Mehra R, Sharma R, Gaffney SG, Perry EB, Townsend JP, Serebriiskii IG, Golemis EA, Issaeva N, Yarbrough WG, et al. Combined Aurora kinase A (AURKA) and WEE1 inhibition demonstrates synergistic antitumor effect in squamous cell carcinoma of the head and neck. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30755439 DOI: 10.1158/1078-0432.Ccr-18-0440 |
0.319 |
|
| 2019 |
Sheth S, Bauman J, Deal A, Chera B, Shen C, Galloway T, Hackman T, Blumberg J, Yarbrough W, Weissler M, Hilliard C, Mehra R, Grilley-Olson J, Weiss J. Pembrolizumab and radiotherapy for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) with contraindication to cisplatin therapy Annals of Oncology. 30: v453. DOI: 10.1093/Annonc/Mdz252.009 |
0.318 |
|
| 2019 |
Beaty B, Gupta G, Shen C, Amdur R, Weiss J, Grilley-Olson J, Patel S, Zanation A, Hackman T, Thorp B, Blumberg J, Patel S, Weissler M, Yarbrough W, Sheets N, et al. PIK3CA Mutation Is an Adverse Prognostic Factor in HPV-Associated Oropharynx Cancer International Journal of Radiation Oncology*Biology*Physics. 105: S215. DOI: 10.1016/J.Ijrobp.2019.06.295 |
0.384 |
|
| 2018 |
Pan C, Issaeva N, Yarbrough WG. HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis. Cancers of the Head & Neck. 3: 12. PMID 31093365 DOI: 10.1186/s41199-018-0039-3 |
0.332 |
|
| 2018 |
Cheraghlou S, Torabi SJ, Husain ZA, Otremba MD, Osborn HA, Mehra S, Yarbrough WG, Burtness BA, Judson BL. HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes. The Laryngoscope. PMID 30151832 DOI: 10.1002/lary.27475 |
0.348 |
|
| 2018 |
Lechner M, Vassie C, Kavasogullari C, Jones O, Howard J, Masterson L, Fenton T, Yarbrough W, Waller J, Gilson R. A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK. Bmj Open. 8: e023339. PMID 30056394 DOI: 10.1136/Bmjopen-2018-023339 |
0.379 |
|
| 2018 |
Pan C, Yarbrough WG, Issaeva N. Advances in biomarkers and treatment strategies for HPV-associated head and neck cancer. Oncoscience. 5: 140-141. PMID 30035167 DOI: 10.18632/oncoscience.425 |
0.324 |
|
| 2018 |
Zhang J, Chen T, Yang X, Cheng H, Späth SS, Clavijo PE, Chen J, Silvin C, Issaeva N, Su X, Yarbrough WG, Annunziata CM, Chen Z, Van Waes C. Attenuated TRAF3 fosters alternative activation of NF-κB and reduced expression of anti-viral interferon, TP53, and RB to promote HPV-positive head and neck cancers. Cancer Research. PMID 29921694 DOI: 10.1158/0008-5472.Can-17-0642 |
0.34 |
|
| 2018 |
Morse E, Judson B, Husain Z, Burtness B, Yarbrough W, Sasaki C, Cheraghlou S, Mehra S. National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiation. Oral Oncology. 82: 122-130. PMID 29909886 DOI: 10.1016/J.Oraloncology.2018.02.010 |
0.308 |
|
| 2018 |
Li H, Torabi SJ, Yarbrough WG, Mehra S, Osborn HA, Judson B. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival. Jama Otolaryngology-- Head & Neck Surgery. PMID 29801040 DOI: 10.1001/jamaoto.2018.0395 |
0.309 |
|
| 2018 |
Loganadane G, Kelly JR, Lee NC, Kann BH, Mahajan A, Hansen JE, Belkacémi Y, Yarbrough W, Husain ZA. Incidence of radiographically occult nodal metastases in HPV+ oropharyngeal carcinoma: Implications for reducing elective nodal coverage. Practical Radiation Oncology. PMID 29730282 DOI: 10.1016/J.Prro.2018.03.009 |
0.397 |
|
| 2018 |
Kelly JR, Park HS, An Y, Yarbrough WG, Contessa JN, Decker R, Mehra S, Judson BL, Burtness B, Husain Z. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer. Oral Oncology. 79: 64-70. PMID 29598952 DOI: 10.1016/J.Oraloncology.2018.02.017 |
0.337 |
|
| 2018 |
Pan C, Biktasova A, Hajek M, Sewell A, Sathe T, Bellinger G, Yarbrough W, Issaeva N. Abstract LB-333: PARP-1 supports HPV infection and HPV-associated head and neck cancer Tumor Biology. DOI: 10.1158/1538-7445.Am2018-Lb-333 |
0.391 |
|
| 2018 |
Kelly JR, Loganadane G, Lee NCJ, Kann BH, Mahajan A, Hansen JE, Belkacemi Y, Yarbrough W, Husain ZA. Incidence of Radiographically Occult Nodal Metastases in HPV-Driven Oropharyngeal Carcinoma: Implications for Reducing Elective Nodal Coverage International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.095 |
0.395 |
|
| 2017 |
Biktasova AK, Hajek M, Sewell AB, Gary CS, Bellinger G, Deshpande H, Bhatia AK, Burtness BA, Judson BL, Mehra S, Yarbrough WG, Issaeva N. Demethylation therapy as a targeted treatment for human papilloma virus-associated head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28916527 DOI: 10.1158/1078-0432.CCR-17-1438 |
0.343 |
|
| 2017 |
An Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, Contessa JN, Decker RH, Koshy M, Husain ZA. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. PMID 28323338 DOI: 10.1002/Cncr.30598 |
0.334 |
|
| 2017 |
Hajek M, Sewell A, Kaech S, Burtness B, Yarbrough WG, Issaeva N. TRAF3/CYLD mutations identify a distinct subset of human papilloma virus-associated head and neck squamous cell carcinoma. Cancer. PMID 28295222 DOI: 10.1002/Cncr.30570 |
0.346 |
|
| 2017 |
Kelly JR, Park HS, An Y, Contessa JN, Yarbrough WG, Burtness BA, Decker R, Husain Z. Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study. Jama Oncology. PMID 28056116 DOI: 10.1001/Jamaoncol.2016.5769 |
0.315 |
|
| 2017 |
Kelly J, An Y, Park H, Yarbrough W, Burtness B, Husain Z. Evaluation of Pathology-Based Staging for HPV-Associated Squamous Cell Carcinoma of the Oropharynx in a Large National Sample International Journal of Radiation Oncology*Biology*Physics. 99: E347. DOI: 10.1016/J.Ijrobp.2017.06.1430 |
0.395 |
|
| 2017 |
Kelly J, An Y, Park H, Yarbrough W, Burtness B, Husain Z. Survival Outcomes Among Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Patients Treated with Upfront Surgery Versus Definitive Chemoradiation Therapy International Journal of Radiation Oncology*Biology*Physics. 99: S43-S44. DOI: 10.1016/J.Ijrobp.2017.06.114 |
0.374 |
|
| 2016 |
Husain ZA, Chen T, Corso CD, Wang Z, Park H, Judson B, Yarbrough W, Deshpande H, Mehra S, Kuo P, Decker RH, Burtness BA. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma. Jama Oncology. PMID 27737449 DOI: 10.1001/Jamaoncol.2016.4581 |
0.423 |
|
| 2016 |
Gary C, Hajek M, Biktasova A, Bellinger G, Yarbrough WG, Issaeva N. Selective antitumor activity of roscovitine in head and neck cancer. Oncotarget. PMID 27233076 DOI: 10.18632/oncotarget.9560 |
0.327 |
|
| 2015 |
Baldassarri R, Aronberg R, Levi AW, Yarbrough WG, Kowalski D, Chhieng D. Detection and genotype of high-risk human papillomavirus in fine-needle aspirates of patients with metastatic squamous cell carcinoma is helpful in determining tumor origin American Journal of Clinical Pathology. 143: 694-700. PMID 25873503 DOI: 10.1016/J.Jasc.2014.09.109 |
0.411 |
|
| 2014 |
Parfenov M, Pedamallu CS, Gehlenborg N, Freeman SS, Danilova L, Bristow CA, Lee S, Hadjipanayis AG, Ivanova EV, Wilkerson MD, Protopopov A, Yang L, Seth S, Song X, Tang J, ... ... Yarbrough WG, et al. Characterization of HPV and host genome interactions in primary head and neck cancers. Proceedings of the National Academy of Sciences of the United States of America. 111: 15544-9. PMID 25313082 DOI: 10.1073/Pnas.1416074111 |
0.408 |
|
| 2014 |
Sewell A, Brown B, Biktasova A, Mills GB, Lu Y, Tyson DR, Issaeva N, Yarbrough WG. Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2300-11. PMID 24599934 DOI: 10.1158/1078-0432.CCR-13-2585 |
0.311 |
|
| 2012 |
Gubanova E, Brown B, Ivanov SV, Helleday T, Mills GB, Yarbrough WG, Issaeva N. Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1257-67. PMID 22247495 DOI: 10.1158/1078-0432.CCR-11-2058 |
0.334 |
|
| 2012 |
Blinov ML, Udyavar A, Yarbrough W, Wang J, Estrada L, Quaranta V. Multi-Network Modeling of Cancer Cell States Biophysical Journal. 102: 22a. DOI: 10.1016/J.Bpj.2011.11.148 |
0.505 |
|
| 2009 |
Baumann JL, Cohen S, Evjen AN, Law JH, Vadivelu S, Attia A, Schindler JS, Chung CH, Wirth PS, Meijer CJ, Snijders PJ, Yarbrough WG, Slebos RJ. Human papillomavirus in early laryngeal carcinoma. The Laryngoscope. 119: 1531-7. PMID 19489068 DOI: 10.1002/Lary.20509 |
0.322 |
|
| 2007 |
Yarbrough WG, Whigham A, Brown B, Roach M, Slebos R. Phosphoinositide kinase-3 status associated with presence or absence of human papillomavirus in head and neck squamous cell carcinomas. International Journal of Radiation Oncology, Biology, Physics. 69: S98-101. PMID 17848307 DOI: 10.1016/j.ijrobp.2007.04.082 |
0.316 |
|
| 2007 |
Wang J, An H, Mayo MW, Baldwin AS, Yarbrough WG. LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. Cancer Cell. 12: 239-51. PMID 17785205 DOI: 10.1016/J.Ccr.2007.07.002 |
0.439 |
|
| 2006 |
Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ, Burkey BB, Netterville JL, Levy S, Yarbrough WG, Chung CH. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 701-9. PMID 16467079 DOI: 10.1158/1078-0432.CCR-05-2017 |
0.303 |
|
| 2006 |
Wang J, He X, Luo Y, Yarbrough WG. A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2. The Biochemical Journal. 393: 489-501. PMID 16173922 DOI: 10.1042/Bj20050960 |
0.458 |
|
| 2006 |
Chung CH, Ely K, Carter J, McGavran L, Varella-Garcia M, Nanney L, Yi Y, Slebos RJ, Yarbrough W, Hirsch FR. High gene copy number of epidermal growth factor receptor by fluorescence in situ hybridization is frequent in head and neck squamous cell carcinomas and associates with worse recurrence-free survival Journal of Clinical Oncology. 24: 5502-5502. DOI: 10.1200/Jco.2006.24.18_Suppl.5502 |
0.316 |
|
| 2005 |
Murphy BA, Shakhtour B, Raben D, Reid W, Weng E, Burkey B, Kish B, Netterville J, Yarbrough W, Cmelak AJ. A phase II multi-institutional trial of chemoradiation (CR) using weekly docetaxel (Doc) and erythropoetin (Epo) for high-risk postoperative head and neck cancer (HRHNC) patients Journal of Clinical Oncology. 23: 5591-5591. DOI: 10.1200/Jco.2005.23.16_Suppl.5591 |
0.301 |
|
| 2004 |
Dwyer KA, Murphy BA, Cmelak AJ, Chung C, Burkey BB, Netterville JL, Yarbrough W, McDowell MR. Predicting psychosocial well-being in head and neck cancer (HNC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 5538. PMID 28013940 DOI: 10.1200/Jco.2004.22.14_Suppl.5538 |
0.331 |
|
| 2004 |
Shores CG, Yin X, Funkhouser W, Yarbrough W. Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma. Archives of Otolaryngology--Head & Neck Surgery. 130: 937-42. PMID 15313863 DOI: 10.1001/Archotol.130.8.937 |
0.363 |
|
| Show low-probability matches. |